Pelthos Therapeutics (NYSEAMERICAN:PTHS) executives detailed the company’s path to the public markets, early commercial ...

Cognition Therapeutics (NASDAQ:CGTX) used its fourth-quarter and full-year 2025 earnings call to outline a shift in ...

Check out the latest action across Billboard's dance charts. By Xander Zellner Billboard’s Dance Moves roundup highlights the biggest movers and shakers across Billboard’s many dance charts, including ...

Taiwan's IC design landscape is undergoing a massive structural shift. Early 2026 revenue data reveals a dual-track performance: while established consumer giants navigate a high-base stabilization ...

As the CBSE board has begun with the final board exams starting from today. CBSE Class 10th Maths Exam is scheduled for 17 Feb, 2026. The exam is conducted from 10:30 am to 1:30 pm. There is only a ...

The MoneyShow Chart of the Day is of the ICE BofA Single-B US High Yield Index Option Adjusted Spread, which shows the extra yield a moderately risky corporate borrower has to offer - above and beyond ...

Katie Stockton, Fairlead, joins 'Fast Money' to take a technical look at bitcoin prices. Trump trade adviser Navarro says administration may force data center builders like Meta to 'internalize' costs ...

Matthew Herper covers medical innovation — both its promise and its perils. SAN FRANCISCO — On Sunday, Alnylam, the gene-silencing company that notched one gigantic accomplishment after another over ...

President Donald Trump began his second term in office with a divided nation and polling numbers – 47% of those surveyed approved of him in January 2025, while 48% disapproved, according to Gallup.